Diabetes abolishes the cardioprotection induced by sevoflurane postconditioning in the rat heart in vivo: Roles of glycogen synthase kinase-3β and its upstream pathways

Journal of Surgical Research

Volumn 178, Issue 1, 2012, Pages 96-104

  Tai, Wenjun ^a   Shi, Enyi ^a   Yan, Lihui ^a   Jiang, Xiaojing ^a   Ma, Hong ^a   Ai, Chunyu ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes; Glycogen synthase kinase; GSK 3 ; Postconditioning; Sevoflurane

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SEVOFLURANE; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME PHOSPHORYLATION; HEART INFARCTION; HEART INFARCTION SIZE; HEART PROTECTION; IN VIVO STUDY; ISCHEMIC POSTCONDITIONING; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; WESTERN BLOTTING;

ANESTHETICS, INHALATION; ANIMALS; CARDIOTONIC AGENTS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; GLYCOGEN SYNTHASE KINASE 3; ISCHEMIC POSTCONDITIONING; MALE; MAP KINASE SIGNALING SYSTEM; METHYL ETHERS; MYOCARDIAL INFARCTION; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84868207926     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.02.021     Document Type: Article

References (42)

1. Z.Q. Zhao, J.S. Corvera, and M.E. Halkos Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning Am J Physiol Heart Circ Physiol 285 2003 H579
2. P. Staat, G. Rioufol, and C. Piot Postconditioning the human heart Circulation 112 2005 2143
3. Z.D. Ge, D. Pravdic, and M. Bienengraeber Isoflurane postconditioning protects against reperfusion injury by preventing mitochondrial permeability transition by an endothelial nitric oxide synthase-dependent mechanism Anesthesiology 112 2010 73
4. D. Obal, S. Dettwiler, and C. Favoccia The influence of mitochondrial KATP-channels in the cardioprotection of preconditioning and postconditioning by sevoflurane in the rat in vivo Anesth Analg 101 2005 1252
5. Y. Jang, J. Xi, and H. Wang Postconditioning prevents reperfusion injury by activating delta-opioid receptors Anesthesiology 108 2008 243
6. D. Obal, B. Preckel, and H. Scharbatke One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo Br J Anaesth 87 2001 905
7. T.H. Lee, E.R. Marcantonio, and C.M. Mangione Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery Circulation 100 1999 1043
8. D.T. Mangano, E.L. Layug, and A. Wallace Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery: Multicenter study of perioperative ischemia research group N Engl J Med 335 1996 1713
9. H.C. Gerstein, P. Pais, and J. Pogue Relationship of glucose and insulin levels to the risk of myocardial infarction: A case-control study J Am Coll Cardiol 33 1999 612
10. J.R. Kersten, W.G. Toller, and E.R. Gross Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality Am J Physiol Heart Circ Physiol 278 2000 H1218
11. K. Tanaka, F. Kehl, and W. Gu Isoflurane-induced preconditioning is attenuated by diabetes Am J Physiol Heart Circ Physiol 282 2002 H2018
12. E.R. Gross, A.K. Hsu, and G.J. Gross Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3beta Diabetes 56 2007 127
13. N. Ghaboura, S. Tamareille, and P.H. Ducluzeau Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling Basic Res Cardiol 106 2011 147
14. H. Eldar-Finkelman, S.A. Schreyer, and M.M. Shinohara Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice Diabetes 48 1999 1662
15. L. Laviola, G. Belsanti, and A.M. Davalli Effects of streptozocin diabetes and diabetes treatment by islet transplantation on in vivo insulin signaling in rat heart Diabetes 50 2001 2709
16. M. Juhaszova, D.B. Zorov, and S.H. Kim Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore J Clin Invest 113 2004 1535
17. M. Nishihara, T. Miura, and T. Miki Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection J Mol Cell Cardiol 43 2007 564
18. L. Argaud, O. Gateau-Roesch, and O. Raisky Postconditioning inhibits mitochondrial permeability transition Circulation 111 2005 194
19. H. Tong, K. Imahashi, and C. Steenbergen Phosphorylation of glycogen synthase kinase-3β during preconditioning through phosphatidylinositol-3- kinase-dependent pathway is cardioprotective Circ Res 90 2002 377
20. X. Jiang, E. Shi, and Y. Nakajima Inducible nitric oxide synthase mediates delayed cardioprotection induced by morphine in vivo: Evidence from pharmacologic inhibition and gene-knockout mice Anesthesiology 101 2004 82
21. X. Jiang, E. Shi, and Y. Nakajima Cyclooxygenase-1 mediates the final stage of morphine-induced delayed cardioprotection in concert with cyclooxygenase-2 J Am Coll Cardiol 45 2005 1707
22. J. Huffmyer, and J. Raphael Physiology and pharmacology of myocardial preconditioning and postconditioning Semin Cardiothorac Vasc Anesth 13 2009 5
23. Y. Inamura, M. Miyamae, and S. Sugioka Aprotinin abolishes sevoflurane postconditioning by inhibiting nitric oxide production and phosphorylation of protein kinase C-delta and glycogen synthase kinase 3beta Anesthesiology 111 2009 1036
24. ATP-channels in the cardioprotection of preconditioning and postconditioning by sevoflurane in the rat in vivo Anesth Analg 101 2005 1252
25. Y.T. Yao, L.H. Li, and L. Chen Sevoflurane postconditioning protects isolated rat hearts against ischemia-reperfusion injury: The role of radical oxygen species, extracellular signal-related kinases 1/2 and mitochondrial permeability transition pore Mol Biol Rep 37 2010 2439
26. Y. Inamura, M. Miyamae, and S. Sugioka Sevoflurane postconditioning prevents activation of caspase 3 and 9 through antiapoptotic signaling after myocardial ischemia-reperfusion J Anesth 24 2010 215
27. S. Tosaka, R. Tosaka, and S. Matsumoto Roles of cyclooxygenase 2 in sevoflurane- and olprinone-induced early phase of preconditioning and postconditioning against myocardial infarction in rat hearts J Cardiovasc Pharmacol Ther 16 2011 72
28. Z. Zheng, M. Yang, and F. Zhang Gender-related difference of sevoflurane postconditioning in isolated rat hearts: Focus on phosphatidylinositol-3-kinase/ Akt signaling J Surg Res 170 2011 e3
29. D. Aguilar, S.D. Solomon, and L. Kober Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial Circulation 110 2004 1572
30. C. Di Filippo, R. Marfella, and S. Cuzzocrea Hyperglycemia in streptozotocin-induced diabetic rat increases infarct size associated with low levels of myocardial HO-1 during ischemia/reperfusion Diabetes 54 2005 803
31. U.D. Dinçer, K.R. Bidasee, and S. Güner The effect of diabetes on expression of beta1-, beta2-, and beta3-adrenoreceptors in rat hearts Diabetes 50 2001 455
32. H.N. Yadav, M. Singh, and P.L. Sharma Involvement of GSK-3β in attenuation of the cardioprotective effect of ischemic preconditioning in diabetic rat heart Mol Cell Biochem 343 2010 75
33. K. Przyklenk, M. Maynard, and D.L. Greiner Cardioprotection with postconditioning: Loss of efficacy in murine models of type-2 and type-1 diabetes Antioxid Redox Signal 14 2011 781
34. A. Tsang, D.J. Hausenloy, and M.M. Mocanu Preconditioning the diabetic heart: The importance of Akt phosphorylation Diabetes 54 2005 2360
35. H.S. Kim, J.E. Cho, and K.C. Hwang Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival Eur J Pharmacol 628 2010 132
36. R.S. Jope, and G.V.W. Johnson The glamour and gloom of glycogen synthase kinase-3 Trends Biochem Sci 29 2004 95
37. S.E. Nikoulina, T.P. Ciaraldi, and S. Mudaliar Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes Diabetes 49 2000 263
38. P.C. Chiari, M.W. Bienengraeber, and P.S. Pagel Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: Evidence for anesthetic-induced postconditioning in rabbits Anesthesiology 102 2005 102
39. J. Raphael, Y. Gozal, and N. Navot Hyperglycemia inhibits anesthetic-induced postconditioning in the rabbit heart via modulation of phosphatidylinositol-3-kinase/Akt and endothelial nitric oxide synthase signaling J Cardiovasc Pharmacol 55 2010 348
40. H.T. Chen, C.X. Yang, and H. Li Cardioprotection of sevoflurane postconditioning by activating extracellular signal-regulated kinase 1/2 in isolated rat hearts Acta Pharmacol Sin 29 2008 931
41. H.S. Kim, J.E. Cho, and K.C. Hwang Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival Eur J Pharmacol 628 2010 132
42. M. Juhaszova, D.B. Zorov, and Y. Yaniv Role of glycogen synthase kinase-3beta in cardioprotection Circ Res 104 2009 1240